SEC Info - Lisata Therapeutics, Inc. - ‘424B5’ on 9/26/22

SEC Info℠

Home

Help

Please Sign In

Lisata Therapeutics, Inc. – ‘424B5’ on 9/26/22

On: Monday, 9/26/22, at 4:20pm ET · Accession #: 320017-22-90 · File #: 333-254971

  As Of               Filer                 Filing    For·On·As Docs:Size

 9/26/22  Lisata Therapeutics, Inc.         424B5                  1:80K

Prospectus – Primary Offering or Shelf Securities – New Facts or Events — Rule 424(b)(5)

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 424B5       Prospectus - Primary Offering or Shelf Securities   HTML     10K 
                - New Facts or Events

Filing Submission 0000320017-22-000090 – SGML Text

Original SGML Text submitted by:	Lisata Therapeutics, Inc. [ formerly Caladrius Biosciences, Inc. ]

To view the SGML, please refresh
this page.

↑Top

Lisata Therapeutics, Inc. – ‘424B5’ on 9/26/22

On: Monday, 9/26/22, at 4:20pm ET · Accession #: 320017-22-90 · File #: 333-254971

Previous ‘424B5’: ‘424B5’ on 6/4/21 · Latest ‘424B5’: This Filing

Prospectus – Primary Offering or Shelf Securities – New Facts or Events — Rule 424(b)(5)Filing Table of Contents

To view the SGML, please refresh this page.

Prospectus – Primary Offering or Shelf Securities – New Facts or Events — Rule 424(b)(5)

Filing Table of Contents

To view the SGML, please refresh
this page.